Intervention
GnRH
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownExploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in MenNCT05773183 · 2023-03-12
UNKNOWNRandomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)NCT03141671 · 2017-11-24
UNKNOWNReprometabolic Syndrome Mediates Subfertility in ObesityNCT02653092 · 2016-06-01
ACTIVE_NOT_RECRUITINGEffects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese WomenNCT01894581 · 2014-07-01
COMPLETEDRapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's CycleNCT00586898 · 2001-07-01
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED2
UNKNOWN2
ACTIVE_NOT_RECRUITING1
Phase mix
NA2
PHASE22
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.